These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23250673)

  • 1. Assessing health status in inflammatory bowel disease using a novel single-item numeric rating scale.
    Surti B; Spiegel B; Ippoliti A; Vasiliauskas EA; Simpson P; Shih DQ; Targan SR; McGovern DP; Melmed GY
    Dig Dis Sci; 2013 May; 58(5):1313-21. PubMed ID: 23250673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
    Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
    Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
    World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life in Korean patients with inflammatory bowel diseases: ulcerative colitis, Crohn's disease and intestinal Behçet's disease.
    Kim WH; Cho YS; Yoo HM; Park IS; Park EC; Lim JG
    Int J Colorectal Dis; 1999 Feb; 14(1):52-7. PubMed ID: 10207731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Activity and Quality of Life Indices Are Valid Across Ulcerative Colitis But Not Crohn's Disease Phenotypes.
    Taleban S; Stewart KO; Li DK; Singh P; Pardi DS; Sturgeon HC; Yajnik V; Xavier RJ; Ananthakrishnan AN; Khalili H
    Dig Dis Sci; 2016 Sep; 61(9):2627-35. PubMed ID: 27142671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Social Support on Psychological Distress and Disease Activity in Inflammatory Bowel Disease Patients.
    Slonim-Nevo V; Sarid O; Friger M; Schwartz D; Sergienko R; Pereg A; Vardi H; Singer T; Chernin E; Greenberg D; Odes S;
    Inflamm Bowel Dis; 2018 Jun; 24(7):1389-1400. PubMed ID: 29893949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers.
    Ricanek P; Brackmann S; Perminow G; Lyckander LG; Sponheim J; Holme O; Høie O; Rydning A; Vatn MH;
    Scand J Gastroenterol; 2011 Sep; 46(9):1081-91. PubMed ID: 21619483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use.
    Subramanian S; Asher R; Weston W; Rimmer M; McConville A; Malin A; Jackson R; Collins P; Probert C; Dibb M; Rhodes JM
    Inflamm Bowel Dis; 2016 Aug; 22(8):1902-7. PubMed ID: 27243590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
    Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the mainland Chinese version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for ulcerative colitis and Crohn's disease.
    Ren WH; Lai M; Chen Y; Irvine EJ; Zhou YX
    Inflamm Bowel Dis; 2007 Jul; 13(7):903-10. PubMed ID: 17309070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease.
    af Björkesten CG; Nieminen U; Turunen U; Arkkila P; Sipponen T; Färkkilä M
    Scand J Gastroenterol; 2012 May; 47(5):528-37. PubMed ID: 22356594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short health scale: A valid measure of health-related quality of life in Korean-speaking patients with inflammatory bowel disease.
    Park SK; Ko BM; Goong HJ; Seo JY; Lee SH; Baek HL; Lee MS; Park DI
    World J Gastroenterol; 2017 May; 23(19):3530-3537. PubMed ID: 28596689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shortened questionnaire on quality of life for inflammatory bowel disease.
    Alcalá MJ; Casellas F; Fontanet G; Prieto L; Malagelada JR
    Inflamm Bowel Dis; 2004 Jul; 10(4):383-91. PubMed ID: 15475746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the influence of disease activity on the quality of life of patients with inflammatory bowel disease using a short questionnaire.
    Casellas F; Alcalá MJ; Prieto L; Miró JR; Malagelada JR
    Am J Gastroenterol; 2004 Mar; 99(3):457-61. PubMed ID: 15056085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
    Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
    World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative and psychometric evaluation of the PROMIS®-Fatigue SF-7a scale to assess fatigue in patients with moderately to severely active inflammatory bowel disease.
    Feagan BG; Sandborn WJ; Sands BE; Liu Y; Vetter M; Mathias SD; Huang KG; Johanns J; Germinaro M; Han C
    J Patient Rep Outcomes; 2023 Nov; 7(1):115. PubMed ID: 37962770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
    Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
    Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocytapheresis in steroid-dependent and steroid-resistant patients with inflammatory bowel disease: a prospective observational study.
    Sacco R; Romano A; Mazzoni A; Bertini M; Federici G; Metrangolo S; Parisi G; Nencini C; Giampietro C; Bertoni M; Tumino E; Scatena F; Bresci G
    J Crohns Colitis; 2013 Dec; 7(12):e692-7. PubMed ID: 23870727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the functional assessment of chronic illness therapy-fatigue (FACIT-F) in patients with inflammatory bowel disease.
    Tinsley A; Macklin EA; Korzenik JR; Sands BE
    Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1328-36. PubMed ID: 21999576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of fecal calprotectin and serum C-reactive protein in early prediction of outcome to infliximab induction therapy.
    Engström J; Lönnkvist M; Befrits R; Ljung T; Diaz-Tartera H; Holst M; Hellström PM
    Scand J Gastroenterol; 2019 Sep; 54(9):1081-1088. PubMed ID: 31499013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.